• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Food and Drug Administration's adverse drug reaction monitoring program.

作者信息

Lee B, Turner W M

出版信息

Am J Hosp Pharm. 1978 Aug;35(8):929-32.

PMID:677138
Abstract

The adverse drug reaction monitoring program of the Division of Drug Experience within the FDA is described. Historical information on the development and activities of the current drug reaction monitoring program, and goals and objectives of the current program are discussed. Also presented are a brief description of the Voluntary Reporting System, intensive drug monitoring studies and special epidemiologic studies, and a workable definition of alert reports and examples of their previous role within the FDA. Pharmacists should participate actively in adverse drug reaction monitoring.

摘要

相似文献

1
Food and Drug Administration's adverse drug reaction monitoring program.
Am J Hosp Pharm. 1978 Aug;35(8):929-32.
2
The pharmacist and adverse drug reaction reporting.药剂师与药品不良反应报告
Hosp Pharm. 1982 Aug;17(8):421-2, 427-30.
3
Postmarketing surveillance.
Can J Hosp Pharm. 1987 Oct;40(5):171-2, 179-80.
4
Physician knowledge, attitudes, and behavior related to reporting adverse drug events.医生与报告药物不良事件相关的知识、态度和行为。
Arch Intern Med. 1988 Jul;148(7):1596-600.
5
Food and Drug Administration monitoring of adverse drug reactions.美国食品药品监督管理局对药品不良反应的监测。
Am J Hosp Pharm. 1986 Nov;43(11):2764-70.
6
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.1969 - 2002年美国药品不良事件监测与药物撤市:报告疑似不良反应的重要性
Arch Intern Med. 2005 Jun 27;165(12):1363-9. doi: 10.1001/archinte.165.12.1363.
7
The state of dietary supplement adverse event reporting in the United States.美国膳食补充剂不良事件报告的现状。
Pharmacoepidemiol Drug Saf. 2008 Oct;17(10):962-70. doi: 10.1002/pds.1627.
8
Adverse drug reaction reporting system: developing a well-monitored program.
Hosp Formul. 1986 Sep;21(9):949-52.
9
Serious adverse events in Norplant users reported to the Food and Drug Administration's MedWatch Spontaneous Reporting System.向美国食品药品监督管理局的MedWatch自发报告系统报告的诺普兰使用者的严重不良事件。
Obstet Gynecol. 1995 Apr;85(4):538-42. doi: 10.1016/0029-7844(94)00457-O.
10
Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.《安全医疗器械法案》:医院遵守美国食品药品监督管理局新要求的管理指南
Hosp Technol Ser. 1993 Oct;12(11):1-27.

引用本文的文献

1
The past, present and perhaps future of pharmacovigilance: homage to Folke Sjoqvist.药物警戒的过去、现在和未来:向 Folke Sjoqvist 致敬。
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:33-41. doi: 10.1007/s00228-013-1486-8. Epub 2013 May 3.
2
Ulcerogenicity of piroxicam: an analysis of spontaneously reported data.吡罗昔康的致溃疡作用:对自发报告数据的分析
Br Med J (Clin Res Ed). 1987 Jan 17;294(6565):147-50. doi: 10.1136/bmj.294.6565.147.